Metropolis Healthcare Ltd.’s first-quarter profit fell, missing estimates.
The diagnostic service provider’s net profit stood at Rs 33 crore in the three months ended June, down 55% over a year earlier, according to its exchange filing. That compares with the Rs 40-crore consensus estimate of analysts tracked by Bloomberg.
Sequentially, too, it fell 16%.
Q1 FY23 Highlights (YoY)
Revenue fell 14% to Rs 280 crore, compared with the Rs 313-crore estimate.
Ebitda was down 33% to Rs 68 crore, against the Rs 74-crore forecast.
Margin contracted to 24.5% from 31.3%. Analysts had projected it at 23.7%.
Shares of Metropolis Healthcare closed 0.62% lower before the results were announced, compared with Sensex ending flat with a negative bias.